India Fibroscan Market Research Report By Technology (Vibration-controlled Transient Electrography (VCTE), Controlled Attenuation Parameter (CAP), Others), By Modality (Portable, Non-Portable/Standalone), By Application (Hepatitis B or C, Nonalcoholic Fatty Liver Disease, Alcohol-related Liver Problems, Hemochromatosis, Others) and By End-user (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Others)- Forecast to 2035

India Fibroscan Market Overview

As per MRFR analysis, the India Fibroscan Market Size was estimated at 3.72 (USD Billion) in 2024.The India Fibroscan Market Industry is expected to grow from 4.5(USD Billion) in 2025 to 8 (USD Billion) by 2035. The India Fibroscan Market CAGR (growth rate) is expected to be around 5.37% during the forecast period (2025 - 2035)

Key India Fibroscan Market Trends Highlighted

The India Fibroscan market is experiencing significant growth driven by an increasing prevalence of liver diseases, particularly Non-Alcoholic Fatty Liver Disease (NAFLD) and Hepatitis C. This rise in liver-related health issues has generated a higher demand for non-invasive diagnostic tools like Fibroscan, which offer effective alternatives to traditional liver biopsy methods. The Indian government’s focus on improving healthcare infrastructure and increasing awareness about liver health has further accelerated the adoption of advanced diagnostic technologies. 

Furthermore, the introduction of initiatives aimed at promoting early detection and treatment of liver conditions has opened up opportunities for market players to expand their offerings.As healthcare providers in India seek to enhance patient outcomes, the availability of Fibroscan technology is set to capture more attention. There is a growing trend in urban areas where hospitals and clinics are increasingly investing in this technology to streamline the diagnosis process, thus reducing the need for invasive procedures. 

Collaborations between healthcare institutions and technology manufacturers also present opportunities to develop tailor-made solutions that address specific regional health issues. Additionally, the rising focus on preventive healthcare and wellness among the population signifies a shift towards routine screening for liver diseases, bolstering the Fibroscan market's prospects.In recent times, digital advancements and telemedicine have facilitated the incorporation of Fibroscan devices in remote areas, thereby broadening access to essential healthcare services. 

The trend toward providing comprehensive health packages that include liver health screenings further highlights the growing importance of Fibroscan in India's medical landscape. With ongoing improvements in technology and the health sector's aim to cater to a large population, the India Fibroscan market continues to evolve and adapt to the healthcare needs of the region.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India Fibroscan Market Drivers

Increasing Prevalence of Liver Diseases in India

The rising prevalence of liver diseases such as hepatitis and cirrhosis in India is a significant driver for the India Fibroscan Market Industry. It is estimated that over 10 million cases of hepatitis are reported in India, according to the National Viral Hepatitis Control Program. This alarming statistic prompts healthcare facilities to seek efficient diagnostic tools like Fibroscan, as non-invasive methods appeal to both patients and healthcare providers.

The World Health Organization highlights that India is home to a considerable percentage of the world's liver disease burden. Further, organizations like the Indian Medical Association have been advocating for advanced diagnostic tools to improve patient care in liver disease management, thereby expanding the Fibroscan market's potential in India.

Growing Awareness and Screening Initiatives

There has been a notable increase in public awareness regarding liver health due to government initiatives and campaigns aimed at educating citizens about liver diseases. The Ministry of Health and Family Welfare in India has launched several awareness programs that emphasize the importance of early diagnosis and treatment of liver diseases. 

With population-level screening programs being introduced, healthcare customers are more likely to seek Fibroscan services, thus positively affecting market growth.The Indian Society of Gastroenterology and other organizations enhancing awareness and education are important for popularizing technologically sophisticated diagnostic tools like Fibroscan.

Technological Advancements in Fibroscan Devices

The technological advancements in medical devices, particularly Fibroscan, have significantly enhanced the effectiveness and efficiency of liver disease diagnosis and monitoring in India. Recent innovations include compact and portable Fibroscan devices that are more user-friendly and can be operated in various healthcare settings including rural areas. Developers are focusing on improving the accuracy and speed of diagnosis, which heightens interest and investment in this market.

Established organizations in the healthcare technology sector are investing in Research and Development to continuously improve Fibroscan capabilities, making these advancements a crucial driver for the India Fibroscan Market Industry.

Government Healthcare Initiatives and Funding

The Indian government has been proactive in launching healthcare initiatives aimed at improving overall health infrastructure. Programs such as the Ayushman Bharat scheme are designed to provide financial protection and improve access to healthcare services, including advanced diagnostic tools like Fibroscan. These initiatives encourage private and public healthcare systems to adopt innovative medical solutions for liver disease management, thus stimulating demand for Fibroscan services.

With significant funding allocated to improve liver health services, the government aims to enhance diagnostic capabilities across the country, contributing positively to the growth of the India Fibroscan Market Industry.

India Fibroscan Market Segment Insights

Fibroscan Market Technology Insights

The India Fibroscan Market highlights the increasing adoption of advanced technologies in the field of liver disease assessment, such as Vibration-controlled Transient (VCTE) and Controlled Attenuation Parameter (CAP). VCTE has become an essential tool in non-invasive liver stiffness measurement, providing accurate insights crucial for diagnosing liver fibrosis, which aligns with India's growing focus on improving liver health amid rising incidences of liver diseases. 

This technology is preferred due to its efficiency and accessibility, making it popular among healthcare providers.CAP, on the other hand, specializes in evaluating liver steatosis, which is especially beneficial in a country where metabolic syndromes are on the rise. 

By allowing for the assessment of fatty liver disease, CAP plays a significant role in the comprehensive management of liver health. Additionally, there are other methods in the Fibroscan segment that contribute to the overall technology landscape, providing alternatives for different clinical scenarios. The combination of these technologies supports the Indian healthcare sector's aim to enhance diagnostic capabilities, thus driving market growth as the demand for non-invasive and accurate testing methods continues to rise.

Furthermore, the increasing awareness regarding liver diseases, along with government initiatives aimed at improving healthcare infrastructure, plays a part in the expanding use of these technologies within India. This aligns with the India Fibroscan Market revenue development, ensuring that advances in technology are effectively integrated into routine practice for better patient outcomes.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Fibroscan Market Modality Insights

The India Fibroscan Market is poised for steady growth, driven by the increasing prevalence of liver diseases and the rising awareness of non-invasive diagnostic techniques. Within the Modality segment, there are two key classifications: Portable and Non-Portable/Standalone systems. Portable Fibroscan devices are particularly significant due to their flexibility and ease of use, making them ideal for various healthcare settings, including rural and remote areas where access to medical facilities may be limited. This enhances the overall penetration of Fibroscan technology across diverse demographics in India.

Conversely, Non-Portable/Standalone units often provide comprehensive diagnostic capabilities and are typically found in hospitals and major healthcare centers, ensuring accurate assessments in a more controlled environment. As India witnesses a surge in demand for advanced medical equipment and technologies, the Fibroscan systems, particularly the portable variety, play a crucial role in bridging the gap in liver disease diagnostics. The growing recognition of the importance of regular health screenings further fuels the market, making it a vibrant focal point within the India Fibroscan Market revenue landscape.

The combination of technological advancements, along with favorable government policies supporting healthcare infrastructure, is encouraging innovations in this sector, thus embodying a robust opportunity for stakeholders involved.

Fibroscan Market Application Insights

The Application segment of the India Fibroscan Market is pivotal in addressing various liver-related health issues prevalent in the region. The increasing incidence of Hepatitis B and C is a significant concern, as these viral infections lead to long-term liver damage, making early detection crucial for effective treatment. Nonalcoholic Fatty Liver Disease has been gaining attention due to rising obesity rates, where lifestyle changes can mitigate severe liver complications, showcasing the need for cost-effective diagnostic tools in this area. 

Alcohol-related liver problems also remain a concerning aspect, as excessive consumption affects a considerable portion of the population.Additionally, Hemochromatosis, a genetic disorder causing iron overload, highlights the need for reliable diagnostic solutions, enabling timely interventions. The diversity of these applications in the India Fibroscan Market reflects the crucial role of innovative diagnostic technologies in improving liver health outcomes. Growing awareness about liver diseases, coupled with advancements in medical technologies, presents significant opportunities for market growth, making it essential to focus on these diverse applications. 

Furthermore, the healthcare infrastructure in India continues to evolve, enhancing access to such diagnostic solutions across urban and rural settings, thereby supporting the overall market dynamics.

Fibroscan Market End-user Insights

The End-user segment of the India Fibroscan Market shows significant growth potential, driven by the increasing prevalence of liver diseases and the need for non-invasive diagnostic methods. Hospitals and clinics are crucial in this landscape, as they provide essential healthcare services and are primary points for patient evaluation and treatment. Diagnostic centers play a vital role by offering specialized testing and ensuring accurate assessments of liver health. Ambulatory Surgical Centers contribute to the market by facilitating outpatient procedures, reducing recovery time and costs for patients.

Other end-users, such as research institutions and specialty practices, further support the diversity of the India Fibroscan Market. As awareness of liver health issues grows among the Indian population, these end-user segments are expected to adapt and invest in advanced Fibroscan technology, thereby driving the overall market growth. Enhancements in healthcare infrastructure, along with evolving government initiatives to combat liver diseases in India, will continue to fuel the demand across these various end-user categories, aligning with the broader trends in the healthcare industry.

India Fibroscan Market Key Players and Competitive Insights

The India Fibroscan Market has been gaining significant traction in recent years, driven by the rising prevalence of liver diseases and an increasing focus on non-invasive diagnostic techniques. This shift has created a competitive environment where various players are striving to enhance the accuracy and efficiency of liver stiffness measurements and fibrosis assessments. The market dynamics are influenced by innovations in technology, strategic collaborations, and the growing importance of early diagnosis and management of liver-related disorders. Players in this sector are capitalizing on the demand for reliable and user-friendly products that can provide rapid and accurate diagnostics, which is vital in a region where liver diseases are becoming increasingly prevalent.

Echosens has established a strong foothold in the India Fibroscan Market, recognized for its cutting-edge innovations and commitment to improving patient outcomes. The company's FibroScan devices stand out due to their non-invasive nature and ability to provide quick and accurate assessments of liver health. Echosens has effectively leveraged local partnerships, enabling deeper penetration in the Indian healthcare ecosystem. Their technology not only addresses the urgent need for reliable liver diagnostics but also is tailored to meet the specific demands of Indian healthcare professionals and patients. 

Echosens continues to focus on enhancing its product offerings and maintaining its leadership position, with a dedication to ongoing research and development, thereby reinforcing its strengths within the competitive landscape.Carestream Health has also positioned itself in the India Fibroscan Market by offering a suite of imaging and diagnostic solutions that cater to a variety of medical needs. While primarily known for its imaging technology, Carestream Health has expanded its portfolio to include Fibroscan solutions that emphasize quick and effective liver analysis. The company’s strengths lie in its advanced imaging technologies and its ability to integrate systems seamlessly into existing healthcare frameworks. 

Carestream Health's strategic alliances and focus on understanding the regional healthcare landscape enable it to innovate effectively and provide solutions that meet the needs of Indian practitioners. Furthermore, the company is active in pursuing mergers and acquisitions, which allows it to enhance its product line and expand its reach in the market, solidifying its position as a notable competitor in the realm of fibroscan diagnostics within India.

Key Companies in the India Fibroscan Market Include

• Echosens


• Carestream Health


• FibriCheck


• VitaScan


• GE Healthcare


• MediFIBER


• Hitachi Medical Systems


• Fujifilm


• Samsung Medison


• Medtronic


• Philips Healthcare


• Toshiba Medical Systems


• Siemens Healthineers


• FIBROSCAN India


• Lumiere Diagnostics

India Fibroscan Market Industry Developments

Recent developments in the India Fibroscan Market indicate increased interest and growth in non-invasive liver diagnostics, primarily driven by advancements from companies like Echosens, Carestream Health, and GE Healthcare. As awareness regarding liver diseases surges in India, the Fibroscan market is witnessing significant technological upgrades, enhancing diagnostic accuracy. Notably, as of September 2023, Echosens expanded its product range in India, emphasizing its commitment to addressing liver health challenges in the region. The market is further supported by partnerships between local healthcare providers and global leaders like Philips Healthcare and Siemens Healthineers, aimed at improving healthcare delivery. 

In terms of mergers and acquisitions, there has been a noteworthy focus on the integration of innovative solutions; however, no recent significant acquisitions directly involving Fibroscan companies have been reported in India as of October 2023. The Fibroscan market valuation in India continues to show promising growth trajectories due to rising investments in healthcare technology and the increasing prevalence of liver diseases. This trend is expected to facilitate better patient care and enhance diagnostic facilities across the healthcare landscape in India, further establishing a competitive edge for key players like Hitachi Medical Systems and MediFIBER.

India Fibroscan Market Segmentation Insights

• 
  Fibroscan Market Technology Outlook
  
  
  
  • Vibration-controlled Transient Electrography (VCTE)
  
  
  
  
  • Controlled Attenuation Parameter (CAP)
  
  
  • Others
  
  


• 
  Fibroscan Market Modality Outlook
  
  
  
  • Portable
  
  
  
  
  • Non-Portable/Standalone
  
  


• 
  Fibroscan Market Application Outlook
  
  
  
  • Hepatitis B or C
  
  
  
  
  • Nonalcoholic Fatty Liver Disease
  
  
  • Alcohol-related Liver Problems
  
  
  • Hemochromatosis
  
  
  • Others
  
  


• 
  Fibroscan Market End-user Outlook
  
  
  
  • Hospitals & Clinics
  
  
  
  
  • Diagnostic Centers
  
  
  • Ambulatory Surgical Centers
  
  
  • Others
  
  

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	3.72(USD Billion)
MARKET SIZE 2024	4.5(USD Billion)
MARKET SIZE 2035	8.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.37% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Echosens, Carestream Health, FibriCheck, VitaScan, GE Healthcare, MediFIBER, Hitachi Medical Systems, Fujifilm, Samsung Medison, Medtronic, Philips Healthcare, Toshiba Medical Systems, Siemens Healthineers, FIBROSCAN India, Lumiere Diagnostics
SEGMENTS COVERED	Technology, Modality, Application, End-user
KEY MARKET OPPORTUNITIES	Growing awareness of liver diseases, Rising prevalence of hepatitis infections, Expanding healthcare infrastructure, Increasing demand for non-invasive diagnostics, Government initiatives for liver health awareness
KEY MARKET DYNAMICS	rising prevalence of liver diseases, increasing awareness about liver health, technological advancements in diagnostic tools, government initiatives for healthcare improvements, growing demand for non-invasive procedures
COUNTRIES COVERED	India